A carregar...
Clinical and research priorities for combined modality therapy in stage III NSCLC
Stage III NSCLC comprises of a heterogeneous group of patients with regard to stage, extent of disease and prognosis. Disease presentation can often be complex in clinical practice, and the challenges are not well-defined in clinical trials or practice guidelines. In order to improve the therapeutic...
Na minha lista:
| Publicado no: | Lung Cancer Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310316/ https://ncbi.nlm.nih.gov/pubmed/30643548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt-2015-0010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|